{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:58:20Z","timestamp":1792695500743,"version":"4.5.0"},"reference-count":69,"publisher":"Oxford University Press (OUP)","issue":"4","content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2015,10]]},"abstract":"<jats:p>Subclinical hypercortisolism (SH), defined as alterations of the hypothalamus\u2013pituitary\u2013adrenal axis in the absence of clinical signs or symptoms related to cortisol secretion, is a common finding in patients with adrenal incidentalomas. The clinical correlates of this pathological condition have become clearer over the last few years. The aim of this review is to summarize the co-morbidities and the clinical outcomes of patients with SH. According to the analysis of the results of the studies published within the last 15 years, hypertension and type 2 diabetes are a common finding in patients with SH, occurring roughly in 2\/3 and 1\/3 of the patients respectively. Moreover, several additional cardiovascular and metabolic complications, like endothelial damage, increased visceral fat accumulation and impaired lipid metabolism have been shown to increase the cardiovascular risk of those patients. Accordingly, recent independent reports investigating the natural history of the disease in a long-term follow-up setting have shown that patients with SH have a higher incidence of cardiovascular events and related mortality. Moreover, longitudinal studies have also shown increased incidence of osteoporotic vertebral fractures. Future research is needed to improve the diagnostic performance of hormonal tests, by assessment of the complete steroid profile with more accurate assays, and to define the efficacy of surgical vs medical treatment in a randomized-controlled setting.<\/jats:p>","DOI":"10.1530\/eje-15-0272","type":"journal-article","created":{"date-parts":[[2015,8,27]],"date-time":"2015-08-27T21:04:23Z","timestamp":1440709463000},"page":"M61-M71","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":104,"title":["Subclinical hypercortisolism: a state, a syndrome, or a disease?"],"prefix":"10.1093","volume":"173","author":[{"given":"Guido","family":"Di Dalmazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato","family":"Pasquali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2015082718040528000_173.4.M61.1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.2.637"},{"key":"2015082718040528000_173.4.M61.2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.87.3.998"},{"key":"2015082718040528000_173.4.M61.3","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-2722"},{"key":"2015082718040528000_173.4.M61.4","doi-asserted-by":"publisher","DOI":"10.1677\/ERC-07-0045"},{"key":"2015082718040528000_173.4.M61.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2007.10.024"},{"key":"2015082718040528000_173.4.M61.6","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.10.4547"},{"key":"2015082718040528000_173.4.M61.7","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-012-9622-2"},{"key":"2015082718040528000_173.4.M61.8","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-013-9992-0"},{"key":"2015082718040528000_173.4.M61.9","doi-asserted-by":"crossref","unstructured":"Schneider HJ Dimopoulou C Stalla GK Reincke M Schopohl J . Discriminatory value of signs and symptoms in Cushing's syndrome revisited: what has changed in 30 years? Clinical Endocrinology 2013 78 153\u2013154. (doi:10.1111\/j.1365-2265.2012.04488.x).","DOI":"10.1111\/j.1365-2265.2012.04488.x"},{"key":"2015082718040528000_173.4.M61.10","unstructured":". NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (\u201cincidentaloma\u201d). NIH Consensus and State-of-the-Science Statements 2002 19 1\u201325."},{"key":"2015082718040528000_173.4.M61.11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0125"},{"key":"2015082718040528000_173.4.M61.12","doi-asserted-by":"crossref","unstructured":"Tabarin A Bardet S Bertherat J Dupas B Chabre O Hamoir E Laurent F Tenenbaum F Cazalda M Lefebvre H . French Society of Endocrinology Consensus. Exploration and management of adrenal incidentalomas. French Society of Endocrinology Consensus. Annales d'Endocrinologie 2008 69 487\u2013500. (doi:10.1016\/j.ando.2008.09.003).","DOI":"10.1016\/j.ando.2008.09.003"},{"key":"2015082718040528000_173.4.M61.13","doi-asserted-by":"crossref","unstructured":"Zeiger MA Thompson GB Duh QY Hamrahian AH Angelos P Elaraj D Fishman E Kharlip J . American Association of Clinical Endocrinologists; American Association of Endocrine Surgeons. The American Association of Clinical Endocrinologists and American Association of Endocrine Surgeons medical guidelines for the management of adrenal incidentalomas. Endocrine Practice 2009 15 (Suppl 1) 1\u201320. (doi:10.4158\/EP.15.S1.1).","DOI":"10.4158\/EP.15.S1.1"},{"key":"2015082718040528000_173.4.M61.14","doi-asserted-by":"crossref","unstructured":"Terzolo M Stigliano A Chiodini I Loli P Furlani L Arnaldi G Reimondo G Pia A Toscano V Zini M . Italian Association of Clinical Endocrinologists. AME position statement on adrenal incidentaloma. European Journal Endocrinology 2011 164 851\u2013870. (doi:10.1530\/EJE-10-1147).","DOI":"10.1530\/EJE-10-1147"},{"key":"2015082718040528000_173.4.M61.15","doi-asserted-by":"crossref","unstructured":"Shen J Sun M Zhou B Yan J . Nonconformity in the clinical practice guidelines for subclinical Cushing's syndrome: which guidelines are trustworthy? European Journal Endocrinology 2014 171 421\u2013431. (doi:10.1530\/EJE-14-0345).","DOI":"10.1530\/EJE-14-0345"},{"key":"2015082718040528000_173.4.M61.16","doi-asserted-by":"crossref","unstructured":"Morelli V Masserini B Salcuni AS Eller-Vainicher C Savoca C Viti R Coletti F Guglielmi G Battista C Iorio L . Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects. Clinical Endocrinology 2010 73 161\u2013166. (doi:10.1111\/j.1365-2265.2010.03794.x).","DOI":"10.1111\/j.1365-2265.2010.03794.x"},{"key":"2015082718040528000_173.4.M61.17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2009.03551.x"},{"key":"2015082718040528000_173.4.M61.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.2010.02436.x"},{"key":"2015082718040528000_173.4.M61.19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1588"},{"key":"2015082718040528000_173.4.M61.20","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.109.136242"},{"key":"2015082718040528000_173.4.M61.21","doi-asserted-by":"publisher","DOI":"10.1159\/000318566"},{"key":"2015082718040528000_173.4.M61.22","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0370"},{"key":"2015082718040528000_173.4.M61.23","doi-asserted-by":"crossref","unstructured":"Iacobone M Citton M Scarpa M Viel G Boscaro M Nitti D . Systematic review of surgical treatment of subclinical Cushing's syndrome. British Journal of Surgery 2015 102 318\u2013330. (doi:10.1002\/bjs.9742).","DOI":"10.1002\/bjs.9742"},{"key":"2015082718040528000_173.4.M61.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2012.12.006"},{"key":"2015082718040528000_173.4.M61.25","doi-asserted-by":"crossref","unstructured":"Androulakis II Kaltsas GA Kollias GE Markou AC Gouli AK Thomas DA Alexandraki KI Papamichael CM Hadjidakis DJ Piaditis GP . Patients with apparently nonfunctioning adrenal incidentalomas may be at increased cardiovascular risk due to excessive cortisol secretion. Journal of Clinical Endocrinology and Metabolism 2014 99 2754\u20132762. (doi:10.1210\/jc.2013-4064).","DOI":"10.1210\/jc.2013-4064"},{"key":"2015082718040528000_173.4.M61.26","doi-asserted-by":"crossref","unstructured":"Giordano R Guaraldi F Berardelli R Karamouzis I D'Angelo V Marinazzo E Picu A Ghigo E Arvat E . Glucose metabolism in patients with subclinical Cushing's syndrome. Endocrine 2012 41 415\u2013423. (doi:10.1007\/s12020-012-9628-9).","DOI":"10.1007\/s12020-012-9628-9"},{"key":"2015082718040528000_173.4.M61.27","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-4276"},{"key":"2015082718040528000_173.4.M61.28","doi-asserted-by":"crossref","unstructured":"Papanastasiou L Pappa T Samara C Apostolopoulou G Tsiavos V Markou A Alexandraki K Piaditis G Chrousos G Kaltsas G . Nonalcoholic fatty liver disease in subjects with adrenal incidentaloma. European Journal of Clinical Investigation 2012 42 1165\u20131172. (doi:10.1111\/j.1365-2362.2012.02707.x).","DOI":"10.1111\/j.1365-2362.2012.02707.x"},{"key":"2015082718040528000_173.4.M61.29","doi-asserted-by":"crossref","unstructured":"Masserini B Morelli V Palmieri S Eller-Vainicher C Zhukouskaya V Cairoli E Orsi E Beck-Peccoz P Spada A Chiodini I . Lipid abnormalities in patients with adrenal incidentalomas: role of subclinical hypercortisolism and impaired glucose metabolism. Journal of Endocrinological Investigation 2015 38 623\u2013628. (doi:10.1007\/s40618-014-0232-0).","DOI":"10.1007\/s40618-014-0232-0"},{"key":"2015082718040528000_173.4.M61.30","doi-asserted-by":"crossref","unstructured":"T\u00f3th M Grossman A . Glucocorticoid-induced osteoporosis: lessons from Cushing's syndrome. Clinical Endocrinology 2013 79 1\u201311. (doi:10.1111\/cen.12189).","DOI":"10.1111\/cen.12189"},{"key":"2015082718040528000_173.4.M61.31","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-031413"},{"key":"2015082718040528000_173.4.M61.32","doi-asserted-by":"crossref","unstructured":"Tauchmanov\u00e0 L Pivonello R De Martino MC Rusciano A De Leo M Ruosi C Mainolfi C Lombardi G Salvatore M Colao A . Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism. European Journal Endocrinology 2007 157 359\u2013366. (doi:10.1530\/EJE-07-0137).","DOI":"10.1530\/EJE-07-0137"},{"key":"2015082718040528000_173.4.M61.33","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03310.x"},{"key":"2015082718040528000_173.4.M61.34","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-0468"},{"key":"2015082718040528000_173.4.M61.35","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.398"},{"key":"2015082718040528000_173.4.M61.36","doi-asserted-by":"crossref","unstructured":"Di Dalmazi G Vicennati V Rinaldi E Morselli-Labate AM Giampalma E Mosconi C Pagotto U Pasquali R . Progressively increased patterns of subclinical cortisol hypersecretion in adrenal incidentalomas differently predict major metabolic and cardiovascular outcomes: a large cross-sectional study. European Journal Endocrinology 2012 166 669\u2013677. (doi:10.1530\/EJE-11-1039).","DOI":"10.1530\/EJE-11-1039"},{"key":"2015082718040528000_173.4.M61.37","doi-asserted-by":"publisher","DOI":"10.1210\/er.2010-0013"},{"key":"2015082718040528000_173.4.M61.38","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-011-9518-9"},{"key":"2015082718040528000_173.4.M61.39","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.2000.15.8.1526"},{"key":"2015082718040528000_173.4.M61.40","doi-asserted-by":"publisher","DOI":"10.1016\/S0039-128X(00)00136-7"},{"key":"2015082718040528000_173.4.M61.41","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-004-1624-3"},{"key":"2015082718040528000_173.4.M61.42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.8.4279"},{"key":"2015082718040528000_173.4.M61.43","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054629"},{"key":"2015082718040528000_173.4.M61.44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2001-011766"},{"key":"2015082718040528000_173.4.M61.45","doi-asserted-by":"crossref","unstructured":"Di Dalmazi G Vicennati V Garelli S Casadio E Rinaldi E Giampalma E Mosconi C Golfieri R Paccapelo A Pagotto U . Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study. Lancet. Diabetes & Endocrinology 2014 2 396\u2013405. (doi:10.1016\/S2213-8587(13)70211-0).","DOI":"10.1016\/S2213-8587(13)70211-0"},{"key":"2015082718040528000_173.4.M61.46","doi-asserted-by":"crossref","unstructured":"Morelli V Reimondo G Giordano R Della Casa S Policola C Palmieri S Salcuni AS Dolci A Mendola M Arosio M . Long-term follow-up in adrenal incidentalomas: an Italian multicenter study. Journal of Clinical Endocrinology and Metabolism 2014 99 827\u2013834. (doi:10.1210\/jc.2013-3527).","DOI":"10.1210\/jc.2013-3527"},{"key":"2015082718040528000_173.4.M61.47","doi-asserted-by":"crossref","unstructured":"Debono M Bradburn M Bull M Harrison B Ross RJ Newell-Price J . Cortisol as a marker for increased mortality in patients with incidental adrenocortical adenomas. Journal of Clinical Endocrinology and Metabolism 2014 99 4462\u20134470. (doi:10.1210\/jc.2014-3007).","DOI":"10.1210\/jc.2014-3007"},{"key":"2015082718040528000_173.4.M61.48","doi-asserted-by":"publisher","DOI":"10.1007\/s002689900441"},{"key":"2015082718040528000_173.4.M61.49","doi-asserted-by":"publisher","DOI":"10.1007\/s002689910095"},{"key":"2015082718040528000_173.4.M61.50","doi-asserted-by":"crossref","unstructured":"Brossaud J Ducint D Corcuff JB . Urinary glucocorticoid metabolites: biomarkers to classify adrenal incidentalomas? Clinical Endocrinology 2015 In press doi:10.1111\/cen.12717).","DOI":"10.1111\/cen.12717"},{"key":"2015082718040528000_173.4.M61.51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.4.1440"},{"key":"2015082718040528000_173.4.M61.52","doi-asserted-by":"crossref","unstructured":"Terzolo M Bovio S Pia A Conton PA Reimondo G Dall'Asta C Bemporad D Angeli A Opocher G Mannelli M . Midnight serum cortisol as a marker of increased cardiovascular risk in patients with a clinically inapparent adrenal adenoma. European Journal Endocrinology 2005 153 307\u2013315. (doi:10.1530\/eje.1.01959).","DOI":"10.1530\/eje.1.01959"},{"key":"2015082718040528000_173.4.M61.53","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-005-0681-x"},{"key":"2015082718040528000_173.4.M61.54","doi-asserted-by":"crossref","unstructured":"Masserini B Morelli V Bergamaschi S Ermetici F Eller-Vainicher C Barbieri AM Maffini MA Scillitani A Ambrosi B Beck-Peccoz P . The limited role of midnight salivary cortisol levels in the diagnosis of subclinical hypercortisolism in patients with adrenal incidentaloma. European Journal Endocrinology 2009 160 87\u201392. (doi:10.1530\/EJE-08-0485).","DOI":"10.1530\/EJE-08-0485"},{"key":"2015082718040528000_173.4.M61.55","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31819a47d2"},{"key":"2015082718040528000_173.4.M61.56","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2008.03492.x"},{"key":"2015082718040528000_173.4.M61.57","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-2387"},{"key":"2015082718040528000_173.4.M61.58","doi-asserted-by":"crossref","unstructured":"Giordano R Marinazzo E Berardelli R Picu A Maccario M Ghigo E Arvat E . Long-term morphological, hormonal, and clinical follow-up in a single unit on 118 patients with adrenal incidentalomas. European Journal Endocrinology 2010 162 779\u2013785. (doi:10.1530\/EJE-09-0957).","DOI":"10.1530\/EJE-09-0957"},{"key":"2015082718040528000_173.4.M61.59","doi-asserted-by":"crossref","unstructured":"Eller-Vainicher C Morelli V Salcuni AS Battista C Torlontano M Coletti F Iorio L Cairoli E Beck-Peccoz P Arosio M . Accuracy of several parameters of hypothalamic\u2013pituitary\u2013adrenal axis activity in predicting before surgery the metabolic effects of the removal of an adrenal incidentaloma. European Journal Endocrinology 2010 163 925\u2013935. (doi:10.1530\/EJE-10-0602).","DOI":"10.1530\/EJE-10-0602"},{"key":"2015082718040528000_173.4.M61.60","doi-asserted-by":"crossref","unstructured":"Alesina PF Hommeltenberg S Meier B Petersenn S Lahner H Schmid KW Mann K Walz MK . Posterior retroperitoneoscopic adrenalectomy for clinical and subclinical Cushing's syndrome. World Journal of Surgery 2010 34 1391\u20131397. (doi:10.1007\/s00268-010-0453-0).","DOI":"10.1007\/s00268-010-0453-0"},{"key":"2015082718040528000_173.4.M61.61","doi-asserted-by":"crossref","unstructured":"Akaza I Yoshimoto T Iwashima F Nakayama C Doi M Izumiyama H Hirata Y . Clinical outcome of subclinical Cushing's syndrome after surgical and conservative treatment. Hypertension Research 2011 34 1111\u20131115. (doi:10.1038\/hr.2011.90).","DOI":"10.1038\/hr.2011.90"},{"key":"2015082718040528000_173.4.M61.62","doi-asserted-by":"crossref","unstructured":"Iacobone M Citton M Viel G Boetto R Bonadio I Mondi I Tropea S Nitti D Favia G . Adrenalectomy may improve cardiovascular and metabolic impairment and ameliorate quality of life in patients with adrenal incidentalomas and subclinical Cushing's syndrome. Surgery 2012 152 991\u2013997. (doi:10.1016\/j.surg.2012.08.054).","DOI":"10.1016\/j.surg.2012.08.054"},{"key":"2015082718040528000_173.4.M61.63","doi-asserted-by":"crossref","unstructured":"Morelli V Palmieri S Salcuni AS Eller-Vainicher C Cairoli E Zhukouskaya V Scillitani A Beck-Peccoz P Chiodini I . Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics. European Journal Endocrinology 2013 168 235\u2013241. (doi:10.1530\/EJE-12-0777).","DOI":"10.1530\/EJE-12-0777"},{"key":"2015082718040528000_173.4.M61.64","doi-asserted-by":"crossref","unstructured":"Perysinakis I Marakaki C Avlonitis S Katseli A Vassilatou E Papanastasiou L Piaditis G Zografos GN . Laparoscopic adrenalectomy in patients with subclinical Cushing syndrome. Surgical Endoscopy 2013 27 2145\u20132148. (doi:10.1007\/s00464-012-2730-5).","DOI":"10.1007\/s00464-012-2730-5"},{"key":"2015082718040528000_173.4.M61.65","doi-asserted-by":"crossref","unstructured":"Palmieri S Morelli V Polledri E Fustinoni S Mercadante R Olgiati L Eller Vainicher C Cairoli E Zhukouskaya VV Beck-Peccoz P . The role of salivary cortisol measured by liquid chromatography-tandem mass spectrometry in the diagnosis of subclinical hypercortisolism. European Journal Endocrinology 2013 168 289\u2013296. (doi:10.1530\/EJE-12-0803).","DOI":"10.1530\/EJE-12-0803"},{"key":"2015082718040528000_173.4.M61.66","doi-asserted-by":"crossref","unstructured":"Vassilatou E Vryonidou A Ioannidis D Paschou SA Panagou M Tzavara I . Bilateral adrenal incidentalomas differ from unilateral adrenal incidentalomas in subclinical cortisol hypersecretion but not in potential clinical implications. European Journal Endocrinology 2014 171 37\u201345. (doi:10.1530\/EJE-13-0848).","DOI":"10.1530\/EJE-13-0848"},{"key":"2015082718040528000_173.4.M61.67","doi-asserted-by":"crossref","unstructured":"Kawate H Kohno M Matsuda M Akehi Y Tanabe M Horiuchi T Ohnaka K Nomura M Yanase T Takayanagi R . Long-term study of subclinical Cushing's syndrome shows high prevalence of extra-adrenal malignancy in patients with functioning bilateral adrenal tumors. Endocrine Journal 2014 61 1205\u20131212. (doi:10.1507\/endocrj.EJ14-0155).","DOI":"10.1507\/endocrj.EJ14-0155"},{"key":"2015082718040528000_173.4.M61.68","doi-asserted-by":"crossref","unstructured":"Kim BY Chun AR Kim KJ Jung CH Kang SK Mok JO Kim CH . Clinical characteristics and metabolic features of patients with adrenal incidentalomas with or without subclinical Cushing's syndrome. Endocrinology and Metabolism 2014 29 457\u2013463. (doi:10.3803\/EnM.2014.29.4.457).","DOI":"10.3803\/EnM.2014.29.4.457"},{"key":"2015082718040528000_173.4.M61.69","doi-asserted-by":"crossref","unstructured":"Ricciato MP Di Donna V Perotti G Pontecorvi A Bellantone R Corsello SM . The role of adrenal scintigraphy in the diagnosis of subclinical Cushing's syndrome and the prediction of post-surgical hypoadrenalism. World Journal of Surgery 2014 38 1328\u20131335.","DOI":"10.1007\/s00268-014-2482-6"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/4\/M61.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/173\/4\/M61.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:32:39Z","timestamp":1676374359000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/173\/4\/M61\/6660787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":69,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0272","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10]]}}}